National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

trilostane
A synthetic derivative of androstane with adrenocortical suppressive properties. Trilostane reversibly inhibits 3 beta-hydroxysteroid dehydrogenase delta 5-4 isomerase in the adrenal cortex, resulting in the decreased synthesis of mineralocorticoids and glucocorticoids and the decreased conversion of pregnenolone to progesterone. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Modrastane
Foreign brand names:Desopan
Modrenal
Code names:WIN 24,540
WIN 24540
WIN 24540
Chemical structure names:
  • (4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile
  • 2Alpha-cyano-4alpha,5alpha-epoxyandrostan-17beta-ol-3-one
  • 4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile



Previous:triciribine phosphate, Tricor, trifluoperazine hydrochloride, trifluridine, Trilisate
Next:trimethoprim-sulfamethoxazole, trimethylcolchicinic acid, trimetrexate glucuronate, Trimox, Triostat

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov